– NYSE:ENFN
stock price today
$10.76
+0.66
+6.64%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 5 hours
stock price monthly change
+14.53%
month
stock price quarterly change
+14.53%
quarter
stock price yearly change
+3.17%
year
key metrics
Market Cap | 993.26M |
Enterprise value | 794.95M |
P/E | -99.6 |
EV/Sales | 5.28 |
EV/EBITDA | 3994.76 |
Price/Sales | 5.65 |
Price/Book | 13.08 |
PEG ratio | -1.03 |
EPS | 0.02 |
Revenue | 181.61M |
EBITDA | 15.62M |
Income | 2.54M |
Revenue Q/Q | 17.28% |
Revenue Y/Y | 15.54% |
Profit margin | -5.09% |
Oper. margin | -7.96% |
Gross margin | 68.67% |
EBIT margin | -7.96% |
EBITDA margin | 8.6% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freestock price history
stock forecast
financial statements
| Jun 2023 | 42.72M | 629K | 1.47% |
|---|---|---|---|
| Sep 2023 | 44.35M | 1.82M | 4.12% |
| Dec 2023 | 46.48M | 623K | 1.34% |
| Mar 2024 | 48.05M | -539K | -1.12% |
| Sep 2025 | 62.44M | 10.07M | 16.14% |
|---|---|---|---|
| Oct 2025 | 62.49M | 8.26M | 13.22% |
| Dec 2025 | 65.02M | 8.90M | 13.69% |
| Mar 2026 | 62.06M | 8.30M | 13.39% |
Analysts Price target
Financials & Ratios estimates
0%
Yield TTM
| Payout ratio | 0% |
|---|
| 2019 | 0.49% |
|---|---|
| 2020 | 0.21% |
| 2021 | 0.24% |
| 2022 | |
| 2023 |
| Jun 2023 | 94053000 | 21.81M | 23.19% |
|---|---|---|---|
| Sep 2023 | 101740000 | 28.46M | 27.98% |
| Dec 2023 | 108972000 | 31.49M | 28.9% |
| Mar 2024 | 110963000 | 28.33M | 25.54% |
| Jun 2023 | 6.01M | -2.21M | -30.84M |
|---|---|---|---|
| Sep 2023 | 12.10M | -2.60M | -5.30M |
| Dec 2023 | 5.43M | -2.29M | 572K |
| Mar 2024 | 1.53M | -2.74M | -1.37M |
alternative data
| Aug 2023 | 1,006 |
|---|---|
| Sep 2023 | 1,006 |
| Oct 2023 | 1,006 |
| Nov 2023 | 1,006 |
| Dec 2023 | 1,006 |
| Jan 2024 | 1,006 |
| Feb 2024 | 1,006 |
| Mar 2024 | 1,102 |
| Apr 2024 | 1,102 |
| May 2024 | 1,102 |
| Jun 2024 | 1,102 |
| Jul 2024 | 1,102 |
other data
5.78%
-27.22%
of ENFN is owned by hedge funds
42
-29
4.93M
-38.54M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jan 2024 | 0 | 10274 |
| Feb 2024 | 0 | 135 |
| May 2024 | 0 | 34059 |
| Jun 2024 | 0 | 36318 |
| Sep 2024 | 0 | 3219 |
| Oct 2024 | 0 | 674 |
| Nov 2024 | 0 | 19226 |
| Dec 2024 | 0 | 72490 |
| Quarter | Transcript |
|---|---|
| Q1 2024 11 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 12 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 11 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 12 Aug 2023 | Q2 2023 Earnings Call Transcript |
Enfusion: Expectations Of Faster Growth And Higher Margins Justify A Buy Rating
Enfusion: TAM Penetration Continues To Progress Well
Enfusion: Product Is Sticky And Industry Is Huge
Enfusion: Still Bullish Considering Q3 EBITDA Beat
SS&C Technologies: Attractive Player In The Financial Services Software Space
Clearwater Analytics Holdings: Valuations Have Run Up Ahead Of The Fundamentals
Enfusion: H2 2023 Growth Acceleration Is The Catalyst To Share Price Rerating
Enfusion: Multiple Catalysts
Enfusion: Still Very Attractive
-
What's the price of stock today?
One share of stock can currently be purchased for approximately $10.76.
-
When is 's next earnings date?
Unfortunately, 's (ENFN) next earnings date is currently unknown.
-
Does pay dividends?
No, does not pay dividends.
-
How much money does make?
has a market capitalization of 993.26M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 16.09% to 174.54M US dollars. earned 6.03M US dollars in net income (profit) last year or $0.01 on an earnings per share basis.
-
What is 's stock symbol?
null is traded on the NYSE under the ticker symbol "ENFN".
-
What is 's primary industry?
Company operates in the Technology sector and Software - Application industry.
-
How do i buy shares of ?
Shares of can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does have?
As Jul 2024, employs 1,102 workers.
-
When went public?
null is publicly traded company for more then 3 years since IPO on 21 Oct 2021.
-
What is 's official website?
The official website for is enfusion.com.
-
Where are 's headquarters?
is headquartered at 125 South Clark Street, Chicago, IL.
-
How can i contact ?
's mailing address is 125 South Clark Street, Chicago, IL and company can be reached via phone at +31 22539800.
company profile:
Exchange:
NYSE
Full time employees:
1,102
Industry:
Software - Application
Sector:
Technology
Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois.
125 South Clark Street
Chicago, IL 60603
Chicago, IL 60603
CIK: 0001868912
ISIN: US2928121043
CUSIP: 292812104
